Indoxyl sulfate (IS), one of the uremic toxins, is regarded to have a substantial role in the progression of chronic kidney disease (CKD). Epithelial-to-mesenchymal transition (EMT) and apoptosis of renal tubular cells are known to be the critical mechanisms of the development and aggravation of CKD. We investigated the effect of IS on EMT and apoptosis in renal proximal tubular cells, NRK-52E cells. IS significantly inhibited cell proliferation and induced cell migration with a morphological transition from cuboidal epithelial cells to spindle-shaped scattered fibroblast-like cells. IS downregulated the expressions of zonula occluden-1 and E-cadherin, whereas upregulated a-SMA expression at 48 h, which was blocked by a pretreatment of the organic anion transporter, probenecid. IS also induced apoptosis of NRK cells from a concentration of 25 mg/ml with an activation of ERK1/2 and p38 MAP kinase (MAPK). Pretreatment of ERK1/2 or p38 MAPK inhibitors, PD98059 or SB203580, resulted in no significant effect on IS-induced EMT, whereas it ameliorated IS-induced apoptosis of NRK cells. These findings suggested phenotypic transition and apoptosis as potential mechanisms of IS-induced renal damage and the differential role of MAPK activation in IS-induced EMT and apoptosis of renal tubular cells. KEYWORDS: apoptosis; chronic kidney disease; epithelial-to-mesenchymal transition; indoxyl sulfate; MAPKinase Indoxyl sulfate (IS) is one of the protein-bound uremic solutes derived from tryptophan, which is converted to indole and subsequently undergoes sulfate conjugation in hepatocytes to form IS.
Indoxyl sulfate (IS) is one of the protein-bound uremic solutes derived from tryptophan, which is converted to indole and subsequently undergoes sulfate conjugation in hepatocytes to form IS. 1 It is taken by organic anion transporters (OATs) at the basolateral membrane of proximal tubular cells, and excreted mostly into urine through tubular secretion. 2 Therefore, IS accumulates in patients with chronic kidney disease (CKD), 3 demonstrated as an increase in serum level and positive immunostaining area of IS in the kidneys. 4 Although IS is regarded as a marker of renal dysfunction, recent data have revealed that IS also has a substantial role in the progression of CKD. 5 Indole, the precursor of IS, caused glomerular sclerosis in uremic rats, 6 and oral administration of IS increased serum creatinine and decreased inulin clearance in uremic rats. 3 In a clinical study, patients with urinary IS levels 490 mg/day showed faster progression rate of CKD than did those with urinary IS o30 mg/day. 7 Furthermore, the administration of oral adsorbent of IS resulted in a decrease in glomerular sclerosis and interstitial fibrosis in uremic rats associated with a decrease in plasma and urinary IS levels. 3 Lowering IS also resulted in an improvement of renal function and a delay in the initiation of dialysis in CKD patients. 8 In a multicenter, randomized clinical study, Schulman et al 9 showed that an administration of AST-120, oral adsorbent of IS, ameliorated uremic symptoms in a dose-dependent manner with a decrease in serum IS and a stable maintenance of serum creatinine. The mechanism of IS-induced renal progression has been explained by an activation of profibrotic cytokines, an induction of oxidative stress and inflammatory mediators. 10 Recent studies have demonstrated the role of phenotypic transition of renal tubular cells in the progression of kidney disease. Epithelial-to-mesenchymal transition (EMT), one of these phenotypic transitions, has been recognized to have pivotal roles in the development and/or aggravation of CKD despite recent debates. 11, 12 Apoptosis of renal tubular cells is also known to contribute to the regulation of renal cell number with an induction and repair of renal injury. 13 Both EMT and apoptosis are major mechanisms of renal injury; however, there have been few studies investigating whether IS-induced renal injury is related to EMT and/or apoptosis of renal tubular cells.
In this study, we examined whether IS per se induced EMT and apoptosis in cultured renal proximal tubular cells, and explored the potential intracellular signaling pathways responsible for IS-induced phenotypic transition and/or death of renal cells.
MATERIALS AND METHODS Reagents
All chemicals and tissue culture plates were obtained from Sigma-Aldrich, St Louis, MO, USA) and Nunc Labware (Waltham, MA, USA), unless otherwise stated.
Cell Culture
Rat renal tubular epithelial cells (NRK-52E cells) were obtained from the American Type Culture Collection (ATCC, Manassas, VA, USA). NRK-52E cells were cultured in Dulbecco's modified Eagle's medium (DMEM) supplemented with 5% fetal bovine serum (FBS), and 60 mg/ml penicillin. Cells were maintained at 371C in a humidified 5% CO 2 /95% air atmosphere incubator. A fresh growth medium was added to the cells every 2 days until cells reached an adequate confluency for each experiment.
Cytotoxicity Assay
Cytotoxicity of IS in NRK-52E cells was determined by the amount of lactate dehydrogenase (LDH) leakage into the medium at 48, 72, and 96 h of IS stimulation (6.25-125 mg/ml) using LDH cytotoxicity detection kit (Roche, Mannheim, Germany). Cytotoxicity was expressed as the percentage of LDH released from IS-stimulated cells to total LDH from cell lysates. Each series of data was determined in triplicate (N ¼ 5).
Cell Proliferation Assay: [ 3 H]-Thymidine Incorporation Assay
The NRK cell was cultured at a concentration of 5 Â 10 4 cells/ ml in 6-well tissue culture plates in DMEM containing 5% FBS. Cells were incubated with IS (from 6.25 to 125 mg/ml) at 371C for 48-96 h, and then [ 3 H]-thymidine (1 mCi/ml) was added. After washing with trichloroacetic acid and phosphate-buffered saline (PBS), cells were solubilized with 2% SDS before quantitation of 
Cell Migration Assay
Cell migration was evaluated as one of the indicators of phenotypic transition. NRK cells were seeded onto the upper chamber of each Transwell (Corning Costar, NJ, USA) at a density of 2 Â 10 5 cells/ml. In 4 h after seeding, the upper chamber was transferred to the lower chamber plate containing the IS (25 or 50 mg/ml) and incubated in a humidified incubator with 5% CO 2 at 371C for 24 h. Non-migratory cells were then scraped off from the top of the Transwell with a cotton swab and cells attached to the bottom side of the Transwell membrane was fixed by 4% paraformaldehyde, and stained with hematoxylin. Cells were counted in five non-overlapping Â 10 fields using a phase-contrast microscope (Olympus CK 30). The experiments were performed in triplicate (N ¼ 5).
Cell Morphology and Fluorescent Immunocytochemistry
After stimulation with IS at concentrations from 6.25 to 50 mg/ml for 24-48 h, morphological changes of NRK-52E cells were examined under an inverted phase-contrast microscope (Axiovert 200; Carl Zeiss, Oberkochen, Germany), and images were obtained by digital camera (AxioCam HRC; Carl Zeiss). For immunofluorescence staining, cells were washed and fixed in 4% phosphate-buffered paraformaldehyde (25 min at 201C) and permeabilized with 1% Triton X-100 in PBS (15 min at 41C). After washing with PBS and blocking with 5% BSA for 1 h, cells were incubated with primary antibodies specific for zonula occluden-1 (ZO-1) (Invitrogen, CA, USA) or a-smooth muscle actin (a-SMA, Sigma-Aldrich) in 5% BSA overnight at 41C, followed by incubation with goat anti-mouse IgG-FITC-conjugated secondary antibody (Santa Cruz Biotechnology, CA, USA) for 1 h at room temperature in the dark. The nucleus was counter-stained with DAPI, and cells were visualized under the Axiovert 200 fluorescence microscope (Carl Zeiss).
Western Blot Analysis
After incubation of renal tubular cells with IS for 48 h to 7 days, protein samples isolated from cell lysates were mixed in reducing buffer, boiled, resolved on 10% SDS-PAGE gels, and transferred to a polyvinylidene difluoride membrane by electroblotting as described previously.
14 Membranes were blocked in 5% wt/vol nonfat milk powder in Tris-buffered saline for 30 min at room temperature. Blots were then incubated overnight in blocking solution with primary antibody at 41C. Mouse mAb to human E-cadherin (BD Bioscience, Bedford, MA, USA) and human a-SMA were used. After washing the blot with Tris-buffered saline with Tween 20, the blots were incubated with alkaline phosphatase-conjugated secondary antibodies corresponding to each primary antibody, followed by enhanced chemiluminescence detection (Santa Cruz Biotechnology). Positive immunoreactive bands were quantified by densitometry and compared with the expression of b-actin.
To examine the activation of ERK1/2 and p38 MAP kinase (MAPK), cells were incubated with IS (25 mg/ml) for 5-120 min before harvesting the protein, and subjected to western blot analysis of ERK1/2, p-ERK1/2 (Santa Cruz Biotechnology), p38, and p-p38 (Santa Cruz Biotechnology).
Real-Time PCR
The levels of E-cadherin and a-SMA transcripts were determined by real time PCR (RT-PCR) on the ABI PRISM 7000 sequence detection system using SYBR Green I as a double-stranded DNA-specific dye according to the manufacturer's instructions (Applied Biosystems, Foster City, CA, USA). The PCR reaction was carried out in 5 ml cDNA, 10 ml of SYBR Green PCR master mix, and 5 pM of sense and antisense primers of E-cadherin or a-SMA (Table 1) for a final volume of 20 ml per reaction. Primer concentrations were determined by preliminary experiments that analyzed the optimal concentrations of each primer. The relative mRNA expression levels of the target genes in each sample were calculated using the comparative C T method. The C T value is the cycle number at which the fluorescence signal is greater than a defined threshold. At least three independent PCR procedures were performed to allow statistical analysis. The amount of PCR products was normalized with the house-keeping gene, b-actin, to determine the relative expression ratios for each mRNA in relation to the control group.
Cell Apoptosis Assay: Flow Cytometric Analysis for PI Staining and Annexin V-FITC Binding
After exposure of NRK cells to IS for 48 h, cell suspensions (1 Â 10 6 cells) were prepared by treating cells with trypsin/ EDTA mixture in DMEM. Cells were washed twice in cold PBS, and then resuspended in 1 Â Annexin V binding buffer at a concentration of 1 Â 10 6 cells/ml. After incubation of 100 ml cell suspension with 5 ml FITC Annexin V and 5 ml propidium iodide (PI) at room temperature (251C) in the dark for 15 min, 400 ml of 1 Â binding buffer was added to each tube. Samples were then analyzed on a FACS Calibur flow cytometer (Beckton Dickinson, San Jose, CA, USA) and CellQuest software (Beckton Dickinson). Early and late apoptosis were assessed by measuring the fraction of Annexin V þ /PIÀ and Annexin V þ /PI þ cells, respectively.
Effects of the Inhibitors of OAT, ERK1/2 or p38 MAPK
To determine whether the effect of IS on EMT and apoptosis required uptake of IS into the cell, cells were pretreated with probenecid (1 mM), an inhibitor of an OAT, which blocked the entry of IS into renal tubular cells for 30 min, and stimulated with IS (25 mg/ml). We also investigated the effect of inhibitors of the ERK1/2 inhibitor (PD98059, 10 mM) or the p38 inhibitor (SB203589, 10 mM) on IS-induced EMT and apoptosis.
Statistical Analysis
All data are presented as mean±s.d. Differences in the various parameters between groups were evaluated by twoway ANOVA, followed by correction for Turkey's multiple comparison analysis. Results were considered significant if the P-value was r0.05.
RESULTS
Effect of IS on Cell Proliferation, Cytotoxicity, and Migration in NRK-52E Cells No significant cytotoxicity was assessed by LDH release in IS-stimulated cells at concentrations of 6.25-25 mg/ml (Figure 1) . Exposure of NRK-52E cells to IS for 48, 72, and 96 hours resulted in an inhibition of proliferation by 460% as compared with control from a concentration of 6.25 mg/ml. Despite a significant inhibition of cell proliferation by IS, IS promoted cell migration, one of the characteristics of EMT of renal tubular cells (Figure 2 ).
Morphological Changes in NRK-52E Cells
Unstimulated NRK-52E cells displayed typical cobblestone morphology of epithelial cells when grown in culture medium ( Figure 3 ). IS induced morphological changes from 48 h of stimulation in NRK-52E cells, which became elongated in shape forming a fibroblast-like morphology with a loss of cell-to-cell contact compared with control cells (Figure 3 ).
Effect of IS on the Expression of ZO-1, E-Cadherin, and a-SMA In association with morphological transformation, we also examined the expressions of ZO-1 as an indication of tightjunction integrity and a-SMA as an indicator of transition to a mesenchymal phenotype. As shown in Figure 4 , there was abundant cellular expression of ZO-1 mainly at the cell membrane in unstimulated renal tubular cells, whereas both membranous and cytoplasmic expression of ZO-1 were much decreased in IS-stimulated cells (Figure 4b ). In addition, IS upregulated a-SMA organization ( Figure 4d ) contrasting with nearly negative staining in untreated cells (Figure 4c) .
Western blot analysis also demonstrated IS-induced alteration in the expression of E-cadherin and a-SMA. With 25 mg/ml of IS, expressions of E-cadherin were decreased to (Figure 5a and b) . In addition, IS from a concentration of 6.25 mg/ml markedly upregulated a-SMA expression at 48 h and 7 days in dose-and time-dependent manners (Po0.05) (Figure 5a and c) . Importantly, pretreatment with probenecid (1 mM) significantly blocked ISinduced changes in the expression of E-cadherin and a-SMA in NRK-52E cells (Po0.05 vs IS-treated cells), suggesting that IS per se entering into cells was responsible for IS-induced EMT ( Figure 6 ). mRNA expression of E-cadherin and a-SMA assessed by quantitative RT-PCR showed the similar findings with western blotting (Figure 7 ).
Effect of IS on Apoptotic Cell Death in NRK-52E Cells
Interestingly, IS per se induced an early apoptosis of NRK-52E cells from a concentration of 25 mg/ml at 48 h of stimulation (36.3 ± 3.7% vs 15.2 ± 5.2%, Po0.05), which was significantly ameliorated with pretreatment of probenecid ( Figure 8 ). The fraction of late apoptosis was negligible with no significant difference between IS-stimulated NRK cells and control.
IS Induced an Activation of ERK1/2 and p38 MAPK To further understand the responsible mechanisms of ISinduced EMT in renal tubular cells, we investigated the activation of ERK1/2 and p38 MAPK signaling pathways by IS stimulation. The increase in ERK1/2 phosphorylation was observed at 5 min, peaked at 10 min (Po0.05 vs 0 min) (Figure 9a and b) . The increase in p38 phosphorylation was also observed at 10 min (Po0.05 vs 0 min) (Figure 9c and d) .
Effect of MAPK Inhibitor on IS-Induced EMT and Apoptosis
Although IS significantly activated ERK1/2 and p38 MAPK, neither the ERK1/2 inhibitor (PD98059, 10 mM) nor the p38 IS-induced EMT and apoptosis SH Kim et al inhibitor (SB203589, 10 mM) ameliorated IS-induced EMT of renal tubular cells (Figure 10 ). However, IS-induced apoptosis of renal tubular cells was inhibited by PD98059 or SB203589 (Figure 11 ).
DISCUSSION
In this study, we have demonstrated that IS per se induced EMT and apoptotic cell death of renal tubular cells with an activation of ERK1/2 and p38 MAPK. MAPK activation by IS was responsible for apoptosis of renal tubular cells; however, it was not related to IS-induced EMT. IS, one of the important uremic toxins, is universally elevated in patients with an impaired renal function as it is mainly eliminated by renal tubular secretion. 1 In patients with decreased glomerular filtration rate (CKD stage 4 or 5), IS level is increased to 8-10 mg/ml, 15 and ESRD patients on maintenance dialysis showed higher levels of IS with the mean and maximal concentrations being approximately 50 and 240 mg/ml, respectively. 16 Although IS has a low molecular weight (213.23 kDa), most of the currently available dialysis modalities including high-flux dialysis do not remove IS effectively, mainly because of the high rate of binding to albumin (96%) in the blood. 17 In this study, we used the concentrations of IS found in CKD patients (6.25-25 mg/ml) to simulate an in vivo environment 17 without inducing cytotoxicity of renal tubular cells. IS is not only a marker of renal dysfunction but has also been known to have an important role in the progression of renal damage by the mechanism of induction of inflammatory reaction, an enhanced production of profibrotic cytokines 5 and reactive oxygen species in endothelial, renal tubular, and mesangial cells. 18, 19 Administration of IS also accelerated the aggravation of renal fibrosis, whereas treatment to decrease IS level resulted in a stabilization of renal function. 3, 6, 20 One of the most important findings of this study was an induction of EMT by IS, which was confirmed by morphological transition and cell migration of cultured murine EMT. 11, 12 The presence of EMT in renal fibrosis was first demonstrated by Strutz et al, 21 and confirmed by others in in vivo and in vitro experiments. 22, 23 Various stimuli such as high glucose, profibrotic cytokines, and inflammatory 
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mediators trigger signals to activate transcription factors of tubular epithelial cells, which in turn induce phenotypic transformation. 24 EMT is characterized by a decrease in the expressions of E-cadherin and ZO-1 protein and an acquisition of de novo a-SMA expression. In our study, IS-induced EMT was observed as early as 48 h of stimulation, and blocked by the OAT, probenecid, suggesting that IS per se entering into cells was responsible for EMT. Furthermore, a-SMA expression was increased from a concentration of as low as 6.25 mg/ml, at which minimal morphological changes were also noted under the microscope. It is necessary to understand that there are controversies regarding the role of EMT in renal fibrosis mainly due to equivocal in vivo evidence of EMT. 12 Nonetheless, there was a growing body of evidence supporting the role of EMT in renal fibrosis using cell fate tracing study 25 or in vitro experiment. 23, 26 Given the consideration of EMT as a continuous process not always a complete process to formation of myofibroblasts, our data clearly demonstrated the direct effect of IS on EMT expressed as a phenotypic transition into mesenchymal cells and an increase in migration of renal tubular cells. This is consistent with the results of a recent study in animal model of chronic tubulointerstitial fibrosis, demonstrating the beneficial effect of AST-120, an oral adsorbent of uremic toxin including IS, on renal fibrosis. 27 AST-120 treatment resulted in an amelioration of EMT of renal tubular cells associated with a decrease in serum IS level.
A second novel finding of this study was that IS inhibited the proliferation with an induction of apoptosis. An inhibitory effect of IS on proliferation of proximal tubular 
cells was found at a relatively low concentration of 6.25 mg/ml in 48 h of stimulation, whereas cell cytotoxicity was detected at a high concentration (125 mg/ml). IS also induced apoptosis of renal tubular cells as early as 48 h at higher concentrations than those inducing EMT. Both apoptosis and inhibition of cell proliferation denote an impaired regeneration or recovery after injury. Although apoptosis is an active process of programmed cell death that is essential to the homeostasis of cell mass, 13 tubular epithelial cell death, mainly through apoptosis, is an early and consistent finding in progressive renal failure. Many experimental studies have demonstrated a role of apoptosis of renal cells as a mediator of renal disease progression in crescentic glomerulonephritis, obstructive nephropathy, and polycystic kidney diseases. [28] [29] [30] On the basis of our in vitro data in NRK cells exposed to IS for 48 h, IS induced EMT at concentrations from 6.25 to 50 mg/ml and early apoptosis at 25 and 50 mg/ml of IS. Early apoptosis observed in IS-stimulated cells was not associated with a significant cytotoxicity expressed as an increase in LDH release. Stimulation of NRK cells with higher concentrations of IS resulted in late apoptosis without inducing EMT. These findings suggested an induction of EMT and/or apoptosis in IS-stimulated cells might depend on the dose of IS exposure. There are several cytokines or growth factors including TGF-b, which are known to induce both EMT and apoptosis of epithelial cells. Yang et al 31 reported that 
TGF-b-induced EMT and apoptosis in AML 12 cells developed through a cell cycle-dependent mechanism, although it does not seem to be an explanation of cell response to IS in our study as we always synchronized the cell cycle of NRK cells by 48-h serum starvation. The next important finding is related to the role of MAPK activation of IS-induced EMT and apoptosis. Although IS clearly activated ERK1/2 and p38 MAPK from 5 min of stimulation, phosphorylation of these MAPKs does not seem responsible for IS-induced EMT, as evidenced by no effect of PD98059 and SB203580 on IS-induced alteration in E-cadherin and a-SMA expressions. In contrast, inhibitors of MAPK significantly ameliorated IS-induced apoptosis of NRK-52E cells. Francescato et al 32 reported that the blockade of p38 MAPK activation is associated with reduction of the inflammatory process, oxidative stress, and apoptotic cell death in cisplatin-induced renal damage. Ciglitazoneinduced cell death was also reduced by transfection of smallinterfering RNA of p38 MAPK, indicating involvement of p38 MAPK in ciglitazone-induced cell death. 33 Transient transfection of cells with constitutive active MEK1, which is an upstream kinase of ERK1/2, increased cisplatin-induced apoptosis. 34 The differential effect of the MAPK inhibitors on EMT and cell apoptosis of renal tubular cells indicated that an activation of MAPK might differentially participate in IS-induced changes in cell phenotype and death. Hashimoto et al 35 reported that a specific inhibitor of the JNK signaling pathway but not an inhibitor of ERK1/2 or p38 MAPK attenuated TGF-b1-induced phenotypic modulation of human lung fibroblasts. Further studies will be necessary to 
examine an activation of another signal transduction pathway, which may be potentially responsible for IS-induced EMT of renal tubular cells. Limitation of this study included the in vitro nature of the experimental setup used. However, a recently published in vivo study examining the effect of IS-lowering therapy on renal fibrosis in a rat model of chronic cyclosporine nephropathy also raised the question regarding a possible role of IS involved in the protective effect of AST-120 on EMT and apoptosis. 27 It was mainly because AST-120 decreased the serum level of other uremic toxins and IS. Therefore, in vivo study actually provided only indirect evidence of IS-induced EMT and apoptosis in renal tubular cells, and introduced substantial complexity in data interpretation. After a recognition of IS as a player of renal disease progression, there have been substantial data investigating the mechanism of IS-induced renal fibrosis, which include an aggravation of renal hypoxia, 36, 37 an induction of endoplasmic reticulum stress demonstrated by an increased expression of C/EBP homologous protein (CHOP), 38 and a production of profibrotic cytokines such as TGF-b and NF-kB. 39 Interestingly, all of these mechanisms are known to induce EMT and apoptosis of renal tubules. Therefore, our findings may provide another rationale for lowering IS in CKD patients to halt the progression of renal disease. Nonetheless, we also need to recognize that not all clinical studies showed a beneficial effect of AST-120 in terms of renal progression, 40 despite an impressing effect in several human studies in the early and late stages of CKD. 8, 41 This may be related to the diversity of risk factors with complex interaction among factors in the aggravation of renal disease.
In conclusion, our data suggested phenotypic transformation and apoptosis as novel mechanisms of IS-induced renal damage. To the best of our knowledge, this study is the first to show the IS-induced EMT and apoptotic cell death in cultured renal tubular cells. Further studies are necessary to examine whether these two mechanisms are also evident in animal models of CKD and to see the effect of IS-lowering therapy on EMT and apoptosis of the kidney.
